| value |
{"aggregator_url":"https://news.google {"aggregator_url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPNlFCbkNoZTJkYXBrbFZteG5HUENYUjlaNFJ1MWIzWVpTVkxBbkE1aHpoelZTYk45RkxfbUlHYjF3dGNDSzBrME5PMVR4VjdYRkVfOC1FMXBOZU1jUDloelplek8yRExzNWlIeGFHa3hYN2xoeGVhLUtVMDZpZ1F4UnY5Rnh2VjFlam5N?oc=5","as_of":"2026-04-13T13:18:39.869325+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPNlFCbkNoZTJkYXBrbFZteG5HUENYUjlaNFJ1MWIzWVpTVkxBbkE1aHpoelZTYk45RkxfbUlHYjF3dGNDSzBrME5PMVR4VjdYRkVfOC1FMXBOZU1jUDloelplek8yRExzNWlIeGFHa3hYN2xoeGVhLUtVMDZpZ1F4UnY5Rnh2VjFlam5N?oc=5","article_chars":0,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_584f4e7eb0f480a4","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-13T16:23:55.555199+00:00","extraction_method":"none","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPNlFCbkNoZTJkYXBrbFZteG5HUENYUjlaNFJ1MWIzWVpTVkxBbkE1aHpoelZTYk45RkxfbUlHYjF3dGNDSzBrME5PMVR4VjdYRkVfOC1FMXBOZU1jUDloelplek8yRExzNWlIeGFHa3hYN2xoeGVhLUtVMDZpZ1F4UnY5Rnh2VjFlam5N?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"realeconomy.rsmus.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPNlFCbkNoZTJkYXBrbFZteG5HUENYUjlaNFJ1MWIzWVpTVkxBbkE1aHpoelZTYk45RkxfbUlHYjF3dGNDSzBrME5PMVR4VjdYRkVfOC1FMXBOZU1jUDloelplek8yRExzNWlIeGFHa3hYN2xoeGVhLUtVMDZpZ1F4UnY5Rnh2VjFlam5N?oc=5","source_event_id":"evt_0ecf92ea2c21","source_quality":"empty","status_code":200,"version":"signal_enrichment_v2"},"fp":"98ca68430039db39","published_at":"2026-04-13T12:48:32+00:00","publisher_domain":"realeconomy.rsmus.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.55,"dates_mentioned":[],"entities":[{"asset_class":"equity/sector","name":"Biopharma markets","relevance":"primary subject","symbol":"","type":"market"}],"event_type":"merger_acquisition","information_gaps":["No article body text is available, so no specific companies, deal sizes, or transaction details can be extracted.","No dates or near-term catalyst timing are provided beyond the general claim of acceleration.","No evidence is provided in the available text for the magnitude of M&A/fundraising changes."],"key_facts":["The Real Economy Blog headline states that biopharma markets are \u201cthawing.\u201d","The headline states that M&A activity is accelerating.","The headline states that fundraising is accelerating."],"numeric_claims":[],"primary_claim":"Biopharma markets are \u201cthawing,\u201d with M&A and fundraising accelerating.","relevance_score":0.35,"sentiment":"positive","source_quality":"unknown","summary":"The headline claims that biopharma markets are improving, with increased M&A activity and fundraising. No specific deals, companies, or timing details are provided in the available text.","topics":["biopharma","M&A","fundraising","market sentiment"]},"source":"The Real Economy Blog","source_domain":"realeconomy.rsmus.com","source_url":"https://realeconomy.rsmus.com","summary":"Biopharma markets thaw: M&A and fundraising accelerate The Real Economy Blog","title":"Biopharma markets thaw: M&A and fundraising accelerate - The Real Economy Blog","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp"}... |